Neuraxis (NRXS) Inventory Average (2023 - 2025)
Neuraxis (NRXS) posted Inventory Average of $183694.0 for Q4 2025, up 52.01% sequentially from $120844.0 in Q3 2025, and up 450.1% YoY from $33393.0 in Q4 2024.
Neuraxis (NRXS) Inventory Average (2023 - 2025) Analysis & Trends
Neuraxis has reported Inventory Average for 3 years, with the latest figure at $183694.0 in Q4 2025.
- Quarterly Inventory Average rose 450.1% year-over-year to $183694.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $183694.0 (up 450.1% YoY) and the FY2025 annual result came in at $150730.0, up 359.91% from the prior year.
- Inventory Average climbed to $183694.0 in Q4 2025 per NRXS's latest filing, from $120844.0 in the prior quarter.
- Over five years, Inventory Average peaked at $183694.0 in Q4 2025 and troughed at $20707.0 in Q1 2024.
- A 3-year average of $61521.8 and a median of $36380.2 in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2025: Inventory Average retreated 17.23% in 2024, then soared 450.1% in 2025.
- Over 3 years, Inventory Average stood at $27875.0 in 2023, then advanced by 19.8% to $33393.0 in 2024, then jumped by 450.1% to $183694.0 in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $183694.0, $120844.0, and $84426.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Neuraxis | 75.51 Mn | 67.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 183,694.00 |
| Sep 30, 2025 | 120,844.00 |
| Jun 30, 2025 | 84,426.50 |
| Mar 31, 2025 | 40,874.50 |
| Dec 31, 2024 | 33,393.00 |
| Sep 30, 2024 | 32,584.00 |
| Jun 30, 2024 | 31,452.00 |
| Mar 31, 2024 | 20,707.00 |
| Dec 31, 2023 | 27,875.00 |
| Sep 30, 2023 | 39,367.50 |